LCMS-8045 Liquid Chromatograph Mass Spectrometer for routine analyses

Article

Sponsored Content

Shimadzu’s new member of the UFMS (Ultra-Fast Mass Spectrometry) family in Europe, the LCMS-8045 offers an optimum balance of sensitivity, robustness, and cost-effectiveness to laboratories performing demanding routine quantitative analyses in areas such as food safety and environmental testing. Ultra-fast technologies improve data acquisition and ensure highly reproducible data even for the most complex matrices. Shimadzu’s LabSolutions software provides options to address specific customer requirements. In case of new challenges or applications requiring higher sensitivity, the LCMS-8045 can be upgraded to the high-sensitivity LCMS-8060.

 

Contact Details:

Shimadzu Europa GmbH
Albert-Hahn-Strasse 6-10
47269 Duisburg, Germany
phone: +49 (0) 203-7687-0
shimadzu@shimadzu.euwww.shimadzu.eu

Recent Videos
Jens Schmidt, associate director MSAT at Lonza
Behind the Headlines episode 8
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Roger Viney, PhD, chief commercial officer for ICE Pharma
Related Content
TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Samsung Biologics Scores Major Manufacturing Deal Worth Over $1.4 Billion with European Pharma Company

Feliza Mirasol
January 17th 2025
Article

Production is set to take place at Samsung Biologics’ Songdo, South Korea, site, and the agreement will run through December 2030, subject to change.

Drug Solutions Podcast: Realizing AI’s Potential

Drug Solutions Podcast: Realizing AI’s Potential

Felicity Thomas
December 20th 2024
Podcast

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Pharmapack Reports on Key Trends for 2025

Feliza Mirasol
January 16th 2025
Article

Pharmapack identifies biologic approvals, drug delivery advancements, GLP-1 generics, and the return of funding flow as drivers for a record year in 2025.

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Drug Solutions Podcast: Dosage Forms: Roundtable on Oral Solid Dosage Trends

Patrick Lavery
October 30th 2024
Podcast

In this podcast episode, we discuss trends in dosage forms, specifically oral solid dosage, as viewed by five industry experts who recently exhibited at CPHI Milan.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

Lonza and Iconovo Team Up on Intranasal Biologic Candidate

Feliza Mirasol
January 15th 2025
Article

Lonza will work with Iconovo to develop spray-dried formulations for an intranasally delivered biologic using a reformulated biologic drug candidate for obesity.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Hikma and Emergent Enter Six-Year Partnership to Sell Naloxone Spray in US and Canada

Patrick Lavery
January 14th 2025
Article

Kloxxado was approved by FDA in 2021 for emergency treatment of opioid overdose, and Emergent also distributes the FDA-approved over-the-counter treatment Narcan.